Protein SSX4
Protein SSX4 (161-180) is a synthetic peptide fragment corresponding to amino acids 161 through 180 of the SSX4 protein, a member of the synovial sarcoma X (SSX) family. These proteins are notable for their involvement in chromatin remodeling and gene regulation, particularly in the context of cancer biology and immunology research. The selected sequence represents a region of SSX4 that may contribute to its antigenic properties or functional interactions within the cell. Synthetic peptides such as this are valuable molecular tools for dissecting protein structure-function relationships, mapping epitopes, and advancing the understanding of protein-protein interactions in both basic and applied research settings.
Epitope mapping: The 161-180 peptide segment of SSX4 is frequently utilized in epitope mapping studies to identify and characterize the specific regions recognized by antibodies or T-cell receptors. By employing this defined peptide in immunoassays, researchers can delineate linear epitopes within SSX4, facilitating the development of monoclonal antibodies or the evaluation of immune responses in model systems. Such mapping efforts are crucial for advancing immunological research and for informing the rational design of immunodiagnostic reagents.
Antigen presentation and immunogenicity studies: As a defined peptide fragment derived from a cancer-testis antigen, the SSX4 (161-180) sequence is often used to investigate the mechanisms of antigen processing and presentation via major histocompatibility complex (MHC) molecules. Researchers employ this peptide to study its binding affinity to specific MHC alleles and to assess T-cell activation in vitro. These experiments provide valuable insights into tumor antigenicity, immune surveillance, and the potential for immunotherapeutic targeting in oncology research.
Protein-protein interaction analysis: The synthetic SSX4 (161-180) peptide serves as a modular probe for studying protein-protein interactions involving the C-terminal region of SSX4. By immobilizing or labeling the peptide, scientists can investigate its binding partners through pull-down assays, surface plasmon resonance, or other biophysical methods. Such studies are instrumental in elucidating the molecular networks and regulatory pathways that involve SSX family proteins, thereby enhancing the understanding of their cellular functions.
Peptide-based assay development: Defined peptide sequences such as SSX4 (161-180) are widely employed in the development and optimization of biochemical assays, including enzyme-linked immunosorbent assays (ELISA) and multiplexed immunoassays. By serving as a standard or calibrator, this peptide enables the quantitative detection of antibodies or other binding molecules specific for SSX4-derived epitopes. The use of synthetic peptides in assay development supports reproducibility and specificity, which are essential for reliable analytical workflows in research laboratories.
Structural and functional studies: Synthetic fragments like the SSX4 (161-180) peptide are valuable for probing the structural and functional properties of the parent protein. Through biophysical characterization and structure-activity relationship analyses, researchers can assess the conformational tendencies, secondary structure, or post-translational modification sites within this region. Such investigations contribute to a deeper understanding of SSX4's molecular architecture and its role in cellular processes, supporting both fundamental and translational research initiatives.
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.